National Institute of Mental Health Multimodal Treatment Study of ADHD Follow-up: 24-Month Outcomes of Treatment Strategies for Attention-Deficit/Hyperactivity Disorder
MTA Cooperative Group*
* The MTA is a cooperative treatment study performed by 6 independent research teams in collaboration with the National Institute of Mental Health and the Office of Special Education Programs of the US Department of Education, Washington, DC
Objective. In the Multimodal Treatment Study of ADHD (MTA), the effects of medication management (MedMgt) and behavior modification therapy (Beh) and their combination (Comb) and usual community comparison (CC) in the treatment of attention-deficit/hyperactivity disorder (ADHD) differed at the 14-month assessment as a result of superiority of the MTA MedMgt strategy (Comb or MedMgt) over Beh and CC and modest additional benefits of Comb over MedMgt alone. Here we evaluate the persistence of these beneficial effects 10 months beyond the 14 months of intensive intervention.
Methods. Of 579 children who entered the study, 540 (93%) participated in the first follow-up 10 months after the end of treatment. Mixed-effects regression models explored possible persisting effects of the MTA medication strategy, the incremental benefits of Comb over MedMgt alone, and the possible superiority of Beh over CC on 5 effectiveness and 4 service use domains.
Results. The MTA medication strategy showed persisting significant superiority over Beh and CC for ADHD and oppositional-defiant symptoms at 24 months, although not as great as at 14 months. Significant additional benefits of Comb over MedMgt and of Beh over CC were not found. The groups differed significantly in mean dose (methylphenidate equivalents 30.4, 37.5, 25.7, and 24.0 mg/day, respectively). Continuing medication use partly mediated the persisting superiority of Comb and MedMgt.
Conclusion. The benefits of intensive MedMgt for ADHD extend 10 months beyond the intensive treatment phase only in symptom domains and diminish over time.
Key Words: ADHD attention deficit hyperactivity stimulant medication behavior therapy
Abbreviations: MTA, Multimodal Treatment Study of ADHD RCT, randomized clinical trial ADHD, attention-deficit/hyperactivity disorder MedMgt, medication management Beh, behavior therapy Comb, combined treatment CC, community comparison ITT, intention-to-treat ODD, oppositional defiant disorder
Received for publication Mar 12, 2003; Accepted Jul 30, 2003.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
A. Faber Taylor and F. E. Kuo Children With Attention Deficits Concentrate Better After Walk in the Park J Atten Disord, March 1, 2009; 12(5): 402 - 409. [Abstract] [PDF] |
||||
![]() |
D. Wallis, H. F. Russell, and M. Muenke Review: Genetics of Attention Deficit/Hyperactivity Disorder J. Pediatr. Psychol., November 1, 2008; 33(10): 1085 - 1099. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Ryan, R. Reid, and C. Ellis Special Educators' Knowledge Regarding Psychotropic Interventions for Students With Emotional and Behavioral Disorders Remedial and Special Education, September 1, 2008; 29(5): 269 - 279. [Abstract] [PDF] |
||||
![]() |
J. Swanson, L. E. Arnold, H. Kraemer, L. Hechtman, B. Molina, S. Hinshaw, B. Vitiello, P. Jensen, K. Steinhoff, M. Lerner, et al. Evidence, Interpretation, and Qualification From Multiple Reports of Long-Term Outcomes in the Multimodal Treatment Study of Children With ADHD (MTA): Part I: Executive Summary J Atten Disord, July 1, 2008; 12(1): 4 - 14. [Abstract] [PDF] |
||||
![]() |
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder Focus, July 1, 2008; 6(3): 401 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Swanson, L. E. Arnold, H. Kraemer, L. Hechtman, B. Molina, S. Hinshaw, B. Vitiello, P. Jensen, K. Steinhoff, M. Lerner, et al. Evidence, Interpretation, and Qualification From Multiple Reports of Long-Term Outcomes in the Multimodal Treatment Study of Children With ADHD (MTA): Part II: Supporting Details J Atten Disord, July 1, 2008; 12(1): 15 - 43. [Abstract] [PDF] |
||||
![]() |
L. M. Furman Attention-Deficit Hyperactivity Disorder (ADHD): Does New Research Support Old Concepts? J Child Neurol, July 1, 2008; 23(7): 775 - 784. [Abstract] [PDF] |
||||
![]() |
V. L. Vetter, J. Elia, C. Erickson, S. Berger, N. Blum, K. Uzark, and C. L. Webb Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Medications for Attention Deficit/Hyperactivity Disorder: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing Circulation, May 6, 2008; 117(18): 2407 - 2423. [Full Text] [PDF] |
||||
![]() |
V A Harpin Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006 Arch. Dis. Child. Ed. Pract., April 1, 2008; 93(2): 58 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. DuPaul and T. J. Power Improving School Outcomes for Students With ADHD: Using the Right Strategies in the Context of the Right Relationships J Atten Disord, March 1, 2008; 11(5): 519 - 521. [PDF] |
||||
![]() |
D. L. Clark, L. E. Arnold, L. Crowl, H. Bozzolo, M. Peruggia, Y. Ramadan, R. Bornstein, J. A. Hollway, S. Thompson, K. Malone, et al. Vestibular Stimulation for ADHD: Randomized Controlled Trial of Comprehensive Motion Apparatus J Atten Disord, March 1, 2008; 11(5): 599 - 611. [Abstract] [PDF] |
||||
![]() |
S. Timimi Child psychiatry and its relationship with the pharmaceutical industry: theoretical and practical issues Adv. Psychiatr. Treat., January 1, 2008; 14(1): 3 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. James Pharmacotherapy and child psychiatry: is there a way forward?: INVITED COMMENTARY ON... CHILD PSYCHIATRY AND ITS RELATIONSHIP WITH THE PHARMACEUTICAL INDUSTRY Adv. Psychiatr. Treat., January 1, 2008; 14(1): 10 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kutzbach, C. G. Summers, A. M. Holleschau, R. A. King, and J. T. MacDonald The Prevalence of Attention-Deficit/ Hyperactivity Disorder Among Persons With Albinism J Child Neurol, December 1, 2007; 22(12): 1342 - 1347. [Abstract] [PDF] |
||||
![]() |
S. P. Hinshaw Moderators and Mediators of Treatment Outcome for Youth With ADHD: Understanding for Whom and How Interventions Work J. Pediatr. Psychol., July 1, 2007; 32(6): 664 - 675. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Strehl, U. Leins, G. Goth, C. Klinger, T. Hinterberger, and N. Birbaumer Self-regulation of Slow Cortical Potentials: A New Treatment for Children With Attention-Deficit/Hyperactivity Disorder Pediatrics, November 1, 2006; 118(5): e1530 - e1540. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schonwald Pediatric Antipsychotic Prescription Rates Soar AAP Grand Rounds, September 1, 2006; 16(3): 25 - 26. [Full Text] [PDF] |
||||
![]() |
H. Ashton, P. Gallagher, and B. Moore The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder J Psychopharmacol, September 1, 2006; 20(5): 602 - 610. [Abstract] [PDF] |
||||
![]() |
C R Steer Managing attention deficit/hyperactivity disorder: unmet needs and future directions Arch. Dis. Child., February 1, 2005; 90(suppl_1): i19 - i25. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Rappley Attention Deficit-Hyperactivity Disorder N. Engl. J. Med., January 13, 2005; 352(2): 165 - 173. [Full Text] [PDF] |
||||
![]() |
Abstracts FOR CHILD AND ADOLESCENT PSYCHIATRY Focus, October 1, 2004; 2(4): 553 - 557. [Full Text] [PDF] |
||||
![]() |
P. Panei, R. Arcieri, S. Vella, M. Bonati, N. Martini, and A. Zuddas Italian Attention-Deficit/Hyperactivity Disorder Registry Pediatrics, August 1, 2004; 114(2): 514 - 514. [Full Text] [PDF] |
||||
![]() |
MTA Cooperative Group National Institute of Mental Health Multimodal Treatment Study of ADHD Follow-up: Changes in Effectiveness and Growth After the End of Treatment Pediatrics, April 1, 2004; 113(4): 762 - 769. [Abstract] [Full Text] [PDF] |
||||

















